focus -WSS

focus

author：hotspot 2025-09-29 01:08:28 - browse：64633

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： HHS's proposed rule does nothing to address the climate crisis

knowledge

WSS

Novel spinal cord stimulator treats paralysis without surgery

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

The creative science of coining drug names

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Novel spinal cord stimulator treats paralysis without surgery

HHS's proposed rule does nothing to address the climate crisis

knowledge

focus

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Welsh Carson private equity firm escapes from FTC antitrust case

Tori Bowie and the unacceptable rates of Black maternal death

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Continuity nursing helped my family in our darkest PICU moments

Brain technologies pose threats that are all too real, experts warn

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lawmakers grill UnitedHealth CEO on Change cyberattack

In age of alternative facts, a scholarly course on calling out crap

The creative science of coining drug names

hotspot

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

China dismisses criticism of top diplomat's comments appearing to push for race

As billionaires fund anti

Novel spinal cord stimulator treats paralysis without surgery

As health system earnings go up, health insurance stocks go down

Primary care doctor shortage won't be solved by free med school tuition

knowledge

hotspot

leisure time

knowledge